Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new humalog clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on humalog
- A Clinical Trial Comparing Efficacy and Safety of Exubera and Humalog
Status: Terminated, Condition Summary: Diabetes Mellitus, Type 1 - Pharmacokinetic (PK),, Pharmacodynamic (PD) of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin R® With and Without rHuPH20
Status: Completed, Condition Summary: Insulin; Diabetes; Volunteers - Exubera vs Lispro in a Lantus-Based Regimen for Improved Glycemic Control in Type 2 Diabetes
Status: Active, not recruiting, Condition Summary: Diabetes Mellitus - Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 2 - A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 2 - Comparison of Two Basal Insulins for Patients With Type 2 Diabetes
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Lispro LM or Biphasic Insulin Aspart 30/70
Status: Recruiting, Condition Summary: Type II Diabetes Mellitus - Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
Status: Recruiting, Condition Summary: Diabetes, Type I - Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
Status: Recruiting, Condition Summary: Diabetes Mellitus - Comparison of Insulins Aspart and Lispro in Insulin Pumps
Status: Active, not recruiting, Condition Summary: Type 1 Diabetes Mellitus; Glycemic Control - Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
Status: Recruiting, Condition Summary: Diabetes Mellitus - Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 1 - Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 2 - A Study for Type 2 Diabetic Patients
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus - A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Status: Completed, Condition Summary: Type 2 Diabetes Mellitus - Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
Status: Active, not recruiting, Condition Summary: Type 1 Diabetes Mellitus - A Study Designed to Compare 2 Formulations of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro
Status: Not yet recruiting, Condition Summary: Diabetes Mellitus, Type 1 - Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes - Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
Status: Enrolling by invitation, Condition Summary: Diabetes Mellitus, Type I - A Study for Patients With Type 1 Diabetes Mellitus
Status: Terminated, Condition Summary: Diabetes Mellitus, Type 1 - A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes Mellitus - A Study for Patients With Diabetes Mellitus
Status: Completed, Condition Summary: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus - Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
Status: Completed, Condition Summary: Type 2 Diabetes; Acute Myocardial Infarction - Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.
Status: Completed, Condition Summary: Diabetes Mellitus, Type 1 - The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes
Status: Active, not recruiting, Condition Summary: Diabetes Mellitus, Type 2 - Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes
Status: Completed, Condition Summary: Diabetes Mellitus, Type 2 - Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
Status: Recruiting, Condition Summary: Diabetes Mellitus, Type 1 - 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
Status: Completed, Condition Summary: Type 2 Diabetes - Lispro Mix 25 vs. Glargine in Type 2 Diabetics
Status: Completed, Condition Summary: Diabetes Mellitus Type 2